Category: Include on Menu
-
Penumbra shares jump as Boston Scientific agrees to $14.5 billion takeover
Boston Scientific Corp (NYSE:BSX) said on Thursday it has reached a deal to acquire medical technology firm Penumbra (NYSE:PEN) for about $14.5 billion, a move aimed at expanding its footprint in cardiovascular devices. Following the announcement, Boston Scientific shares fell roughly 4%, while Penumbra stock surged more than 13% in U.S. premarket trading. Under the…
-
Kroger broadens grocery delivery reach through Uber Eats and Postmates
Kroger Co. (NYSE:KR) has rolled out its grocery delivery offering on the Uber Eats, Uber, and Postmates apps, extending on-demand and same-day delivery to customers from nearly 2,700 stores across the United States. Through the delivery platforms, shoppers can browse full assortments from multiple Kroger-owned banners, including Ralphs and Fred Meyer, and place orders directly…
-
Goldman Sachs revenue edges lower as Apple Card transition weighs
Goldman Sachs (NYSE:GS) reported a decline in fourth-quarter net revenues, citing a markdown tied to the transfer of Apple’s large credit-card partnership to JPMorgan Chase. Despite the revenue dip, earnings surpassed expectations. The firm said the markdown was more than offset by a $2.48-billion reduction in provisions for credit losses, which lifted the bottom line…
-
U.S. Import Prices Rise Between September and November
U.S. import prices increased over the period from September to November, according to figures released Thursday by the Labor Department. The data showed that import prices climbed 0.4% across the two-month span, reversing a 0.1% decline recorded in September and signalling a pickup in costs for goods entering the United States toward the end of…
-
U.S. Jobless Claims Fall Sharply, Undershooting Forecasts
New filings for US unemployment benefits declined in the latest reporting week, coming in below both market expectations and the prior week’s level, according to fresh economic data. Initial jobless claims totalled 198,000, well under the consensus forecast of 215,000. The lower-than-expected reading is generally viewed as a positive signal for the US labour market…
-
Tech Shares Poised to Drive Early Wall Street Bounce: Dow Jones, S&P, Nasdaq, Futures
US equity futures pointed to a firmer open on Thursday, suggesting stocks may recover some ground after losses over the previous two sessions. Technology shares were set to lead the rebound, with Nasdaq 100 futures up around 1.0%, reflecting renewed buying interest in the sector. The improved tone in tech was partly driven by a…
-
Amazon Unveils AWS European Sovereign Cloud With €7.8 Billion Investment Plan
Amazon Web Services (NASDAQ:AMZN) has announced the general availability of the AWS European Sovereign Cloud, a standalone cloud platform built exclusively to meet Europe’s data sovereignty and regulatory requirements. The new cloud environment is hosted entirely within the European Union and operates as a physically and logically independent infrastructure, separate from other AWS Regions worldwide.…
-
TSMC Crushes Expectations With Record Profit and Signals Further US Expansion
TSMC (NYSE:TSM), the world’s leading producer of advanced AI chips, on Thursday reported a forecast-beating 35% surge in fourth-quarter profit to a record level, outlined strong growth expectations for the year ahead and indicated that additional manufacturing capacity in the United States is being planned. Buoyed by what it described as the “AI mega trend”,…
-
Coinbase CEO Pushes Back on Key US Crypto Bill, Raising Regulatory Uncertainty
Coinbase Global Inc (NASDAQ:COIN) Chief Executive Brian Armstrong said on Wednesday that the largest US cryptocurrency exchange cannot support a major draft crypto regulation bill in its current form, casting doubt on the legislation as it heads toward consideration in the Senate. Armstrong told lawmakers and industry participants that the proposal, which was introduced in…
-
Sanofi Weighs Improved Bid for Ocular Therapeutix Following Board Rejection
Sanofi (EU:SAN) is reportedly preparing to submit a higher takeover proposal for Ocular Therapeutix (NASDAQ:OCUL) after the US biotech company’s board turned down an initial offer valuing the shares at $16 each, according to a report by La Lettre. Ocular Therapeutix shares rose 6.1% in Wednesday’s trading session to close at $11.07, implying a market…